Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2026 09:00 ET | Source: Nasus Pharma, Ltd.

Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update

Recent Phase 2 topline results demonstrate NS002’s potential for best-in-class epinephrine delivery, with statistically significant improvements in early absorption compared to EpiPen®; pivotal study...
March 24, 2026 09:46 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting...
March 24, 2026 09:00 ET | Source: Worth

Worth Raises $30 Million in Series A Funding to Fuel Record Growth

ORLANDO, Fla., March 24, 2026 (GLOBE NEWSWIRE) -- Worth, the fintech platform modernizing onboarding and underwriting Small and Medium-sized Businesses (SMB) for Financial Institutions, has...
March 24, 2026 08:37 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting...
March 24, 2026 08:15 ET | Source: Harrow, Inc.

Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth

NASHVILLE, Tenn., March 24, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it intends to offer,...
March 24, 2026 07:00 ET | Source: Public Policy Holding Company, Inc.

PPHC Added to Russell 2000® and Russell 3000® Indexes

Inclusion Comes Shortly After Completion of U.S. IPO WASHINGTON, March 24, 2026 (GLOBE NEWSWIRE) -- Public Policy Holding Company, Inc. (“PPHC” or “the Company”) (Nasdaq: PPHC) (AIM: PPHC.L), a...
March 24, 2026 03:30 ET | Source: GEVORKYAN, a.s.

Akvizícia bez zadlženia. Navýšenie free float.

GEVORKYAN, a.s. oznamuje úspešnú realizáciu ABB, na základe ktorej získala kapitál na ďalší rozvoj výrobných kapacít, technologické inovácie a posilnenie svojho postavenia na medzinárodných trhoch,...
March 24, 2026 03:30 ET | Source: GEVORKYAN, a.s.

Akvizice bez zadlužení. Navýšení free float.

GEVORKYAN, a.s. oznamuje úspěšnou realizaci ABB, na jejímž základě získala kapitál na další rozvoj výrobních kapacit, technologické inovace a posílení svého postavení na mezinárodních trzích, včetně...
March 24, 2026 03:30 ET | Source: GEVORKYAN, a.s.

Debt-Free Acquisition. Increase in Free Float.

GEVORKYAN, a.s. announces the successful completion of ABB, through which it obtained capital for the further development of its production capacities, technological innovation, and strengthening of...
March 23, 2026 13:26 ET | Source: Grupo Aeroportuario del Pacífico, S.A.B. de C.V.

Grupo Aeroportuario del Pacifico Announces the Obtaining of Independent Assurance on the KPI of Its Sustainability-Linked Bonds “GAP 22L,” “GAP 23L,” “GAP 23-2L,” “GAP 24L,” and “GAP 24-2L”

GUADALAJARA, Mexico, March 23, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces that, in connection with its...